Anthem Blue Cross Blue Shield to Cover MCT
Anthem Blue Cross & Blue Shield recently announced that they plan to reveal their coverage determination for mobile cardiac telemetry (MCT) monitoring. This marks a big step in advancing mobile cardiac telemetry monitoring to another estimated 40 million patients.
Mobile cardiac telemetry monitoring is the known to be the most advanced form of ambulatory cardiac monitoring as it automatically detects & automatically transmits abnormal ECG rhythms to an outpatient laboratory in (virtually) real time. This advanced form of outpatient cardiac monitoring represents an opportunity to expedite the gathering of cardiac ECG data without having to order a range of additional forms of cardiac monitoring tests such as 24 hour Holter monitoring, extended long term continuous ECG monitoring or traditional cardiac event monitoring. Mobile cardiac telemetry is deemed exciting for the industry as it represents a legitimate opportunity to control & lower healthcare costs associated with redundant outpatient ECG studies.
For more information about this exciting form of ambulatory cardiac monitoring, click Mobile Cardiac Telemetry (MCT).